O-aryl glucoside sglt2 inhibitors and method

Details for Australian Patent Application No. 2001249598 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wu, Gang; Washburn, William N.; Sher, Philip M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001249598

PCT Pub. Number WO01/74834

Priority 60193094 30.03.00 US

Filing date 29 March 2001

Wipo publication date 15 October 2001

Acceptance publication date 7 September 2006

International Classifications

C07H 15/203 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07B 61/00 (2006.01) Other general methods

Event Publications

7 September 2006 Application Accepted

  Published as AU-B-2001249598

24 May 2007 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001249599-O-glucosylated benzamide sglt2 inhibitors and method

2001249597